Cargando…
Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice
Autores principales: | Agca, Rabia, Smulders, Yvo, Nurmohamed, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666803/ https://www.ncbi.nlm.nih.gov/pubmed/33674356 http://dx.doi.org/10.1136/heartjnl-2019-316378 |
Ejemplares similares
-
Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients
por: Blanken, Annelies B., et al.
Publicado: (2022) -
Assessment and management of cardiovascular disease in the intensive care unit
por: Cook, David Jonathan, et al.
Publicado: (2022) -
Imaging as a surrogate marker of drug efficacy in cardiovascular disease
por: Tarkin, Jason M, et al.
Publicado: (2019) -
Pregnancy in congenital heart disease: risk prediction and counselling
por: van Hagen, Iris M, et al.
Publicado: (2020) -
Implementing an early rule-out pathway for acute myocardial infarction in clinical practice
por: Lowry, Matthew T H, et al.
Publicado: (2021)